Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

NCT00363311 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Prostate

Interventions

DRUG: Dutasteride
DRUG: Matching placebo

Sponsor

GlaxoSmithKline